Hologic (HOLX) Tops Q3 EPS by 24c

Hologic (NASDAQ: HOLX) reported Q3 EPS of $0.95, $0.24 better than the analyst estimate of $0.71. Revenue for the quarter came in at $1 billion versus the consensus estimate of $904.49 million.

GUIDANCE:

Hologic sees Q4 2022 EPS of $0.60-$0.65, versus the consensus of $0.61. Hologic sees Q4 2022 revenue of $840-870 million, versus the consensus of $869.95 million.

Hologic sees FY2022 EPS of $5.79-$5.84, versus the consensus of $5.56. Hologic sees FY2022 revenue of $4.75-4.78 billion, versus the consensus of $4.68 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Occidental Petroleum releases Q2 2026 earnings considerations
• Delta Air shares slip despite strong outlook, Melius says